chronische pijn aan houdings- en bewegingsapparaat chronic musculoskeletal disorders chronic musculoskeletal pain
Conditions
Interventions
Reference 100 hours intervention:
The reference intervention is delivered over 15 weeks with two sessions (~3,5 h
/ session) per week. The reference intervention encompasses several modules:
return
conducted by fourteen rehabilitation
centers, and of which four will participate in this study.
Experimental 40 hours intervention:
The experimental program lasts maximally 40 hours in 15 weeks. Th
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1) Working age individuals (18-65 years) 2) Suffering from subacute (6-12 weeks) or chronic non-specific musculoskeletal pain (>12 weeks) such as back, neck, shoulder, widespread pain, whiplash (WAD I or II), or fibromyalgia 3) Having paid work (employed or self-employed) for at least 12 hours per week 4) The expectation that there will be no termination of the employment or self-employment in the year following the vocational rehabilitation program 5) Having short-term (=6 weeks) part-time or full-time sick leave 6) Being able to understand Dutch and to complete questionnaires in Dutch 7) Having the motivation to participate in the vocational rehabilitation program aimed to optimize work participation 8) Reimbursement of the program costs that are not covered by health care insurers 9) Having an email address 10) Having signed informed consent.
Exclusion criteria
Exclusion criteria: 1) having comorbidities which are the primary reason for sick leave, such as clinical depression or burnout, severe asthmatic symptoms, diagnosed chronic fatigue, and neuropathy 2) having a conflict with the employer, which is the primary reason for sick leave
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome in this study is work participation, expressed as cumulative sick leave days due to subacute or chronic musculoskeletal pain during the training period and from discharge until 12-months follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Productivity loss, work ability, disability, quality of life, and physical functioning. | — |
Countries
Netherlands
Outcome results
None listed